Free Trial

Definitive Healthcare (DH) Stock Forecast & Price Target

$5.84
-0.18 (-2.99%)
(As of 07/24/2024 ET)

Definitive Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 10 Wall Street analysts who have issued ratings for Definitive Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 10 analysts, 8 have given a hold rating, and 2 have given a buy rating for DH.

Consensus Price Target

$9.56
63.74% Upside
High Forecast$15.00
Average Forecast$9.56
Low Forecast$7.00

According to the 10 analysts' twelve-month price targets for Definitive Healthcare, the average price target is $9.56. The highest price target for DH is $15.00, while the lowest price target for DH is $7.00. The average price target represents a forecasted upside of 63.74% from the current price of $5.84.

TypeCurrent Forecast
7/26/23 to 7/25/24
1 Month Ago
6/26/23 to 6/25/24
3 Months Ago
4/27/23 to 4/26/24
1 Year Ago
7/26/22 to 7/26/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
8 Hold rating(s)
9 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$9.56$9.94$11.31$14.29
Forecasted Upside63.74% Upside29.37% Upside19.85% Upside13.25% Upside
Get Definitive Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter.

DH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Definitive Healthcare Stock vs. The Competition

TypeDefinitive HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.18
2.72
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside70.28% Upside3,257.63% Upside10.62% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/14/2024William Blair
2 of 5 stars
 Reiterated RatingOutperform
5/9/2024Deutsche Bank Aktiengesellschaft
2 of 5 stars
 Lower TargetHold ➝ Hold$10.00 ➝ $7.00+36.19%
5/9/2024Barclays
2 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$11.00 ➝ $7.00+31.33%
5/8/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$10.00 ➝ $8.00+58.42%
5/8/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$11.00 ➝ $9.50+83.04%
5/8/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
5/8/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$11.50 ➝ $9.00+24.14%
8/16/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$17.00 ➝ $10.50+3.65%
8/15/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$12.00 ➝ $10.50+0.19%
7/24/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$13.00+12.75%
2/24/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$19.00 ➝ $15.00+26.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:23 AM ET.

DH Forecast - Frequently Asked Questions

What is Definitive Healthcare's forecast for 2024?

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Definitive Healthcare is $9.56, with a high forecast of $15.00 and a low forecast of $7.00.

Should I buy or sell Definitive Healthcare stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.

Does Definitive Healthcare's stock price have much upside?

According to analysts, Definitive Healthcare's stock has a predicted upside of 33.28% based on their 12-month stock forecasts.

Has Definitive Healthcare been downgraded by Wall Street analysts recently?

Over the previous 90 days, Definitive Healthcare's stock had 1 downgrade by analysts.

What analysts cover Definitive Healthcare?

Definitive Healthcare has been rated by research analysts at Barclays, Canaccord Genuity Group, Deutsche Bank Aktiengesellschaft, Morgan Stanley, Needham & Company LLC, Stifel Nicolaus, and William Blair in the past 90 days.

Do Wall Street analysts like Definitive Healthcare more than its competitors?

Analysts like Definitive Healthcare less than other "medical" companies. The consensus rating for Definitive Healthcare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how DH compares to other companies.


This page (NASDAQ:DH) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners